NYU Langone Insights on Psychiatry

Dr. Christopher Pittenger is a Professor of Psychiatry at the Yale School of Medicine and Director of the Yale OCD Research Clinic . In this episode, he discusses the neurobiology, symptomology, and treatment of Obsessive-Compulsive Disorder (OCD), including potential new treatments such as psychedelics, neurofeedback, glutamate modulators, and transcranial magnetic stimulation (TMS).  00:00 Intro...

Dr. Richard Davidson is the William James and Vilas Professor of Psychology and Psychiatry at the University of Wisconsin–Madison and Founder & Director of the Center for Healthy Minds .  In this episode, he discusses the current state of research on mindfulness and meditation as mental health interventions. 00:00 Introduction 02:15 Focus areas in current research 04:37 Well-being as a univers...

Dr. Ronald Kessler is the McNeil Family Professor of Health Care Policy at Harvard Medical School. His groundbreaking work on the social determinants of mental health, studied from an epidemiological perspective, has made him the most widely cited psychiatric researcher in the world.  In this wide-ranging conversation, he talks about precision psychiatry's enormous potential and incremental d...

Dr. Petros Levounis is President of the American Psychiatric Association and a leader in addiction research. He joins host Thea Gallagher, PsyD, to talk about the latest in addiction medicine, the state of the opioid crisis, the growing problem of technology addiction, and the promise and risks of psychedelic medicine. He also shares his hopes for the future of psychiatry, including better integra...

Starting this fall, we're releasing 12 more conversations with the best minds in psychiatry. Subscribe wherever you're listening, so you won't miss an episode. This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle

Dr. Carla Nasca is an Assistant Professor in the Department of Psychiatry and the Department of Neuroscience and Physiology at NYU Langone, where she studies epigenetic mechanisms of neuroplasticity to stress. Dr. Nasca's work led to the discovery of acetyl-L-carnitine (LAC), a metabolite found in the mitochondria, as a promising biological marker of depression. Topics: acetyl-L-carnitine (LA...

Dr. Tanya Sippy is an Assistant Professor in the Department of Psychiatry and the Department of Neuroscience and Physiology at NYU Langone. She’s also Principal Investigator at the Sippy Lab and Associate Director of the Psychedelic Medicine Research Training Program. Her research explores the neural mechanisms that underlie how sensory stimuli become associated with goal-directed behavior.  Topic...

Dr. Andrew Nierenberg is a Professor of Psychiatry at Harvard Medical School and Director of the MGH Dauten Family Center for Bipolar Treatment Innovation. He completed his residency in psychiatry at New York University/Bellevue Hospital. Topics: Lithium vs antipsychotics SMART BD (Sequential Multiple Assignment of Randomized Treatment) Bipolar Learning Health Network Medication concordance More i...

Dr. Alan Schatzberg is a Professor of Psychiatry and Behavioral Sciences at Stanford Medicine, and Director of the Stanford Mood Disorders Center. His research examines the biology and psychopharmacology of depressive disorders. An NYU School of Medicine alumnus, Dr. Schatzberg was President of the American Psychiatric Association from 2009-2010. Topics: Ketamine and Esketamine (incl. mechanisms o...

Dr. Michael Bogenschutz is a Professor of Psychiatry at the NYU Grossman School of Medicine, and Director of the NYU Langone Center for Psychedelic Medicine . Topics: Psilocybin-assisted psychotherapy for alcohol use disorder MDMA-assisted psychotherapy for PTSD Psychedelic medicine for the "worried well" The role of the mystical experience Comparing different psychedelic medicines Mecha...

Dr. Omonigho M. Bubu is an Assistant Professor of Psychiatry and Population Health at the NYU Grossman School of Medicine, where he studies the connection between sleep and neurodegenerative diseases, as well as social determinants of health as they relate to cognitive health. In this interview, he discusses the importance of sleep, especially for people at higher risk of developing Alzheimer’s di...

Naomi Simon, MD, talks about her research into mindfulness-based stress reduction (MBSR) and yoga as treatments for anxiety disorders. Dr. Simon is a Professor in the Department of Psychiatry at the NYU Grossman School of Medicine, and Director of the Anxiety, Stress, and Prolonged Grief Program . Topics: Generalized Anxiety Disorder (GAD) Mindfulness-Based Stress Reduction (MBSR) Kundalini yoga S...

Mohammed Milad, PhD , discusses recent research into fear conditioning, regulation, and extinction. Dr. Milad is a Professor in the Department of Psychiatry at the NYU Grossman School of Medicine and Director of the Behavioral Neuroscience Program. Topics covered: Transcranial magnetic stimulation (TMS) Estrogen and PTSD Post-traumatic stress disorder (PTSD) Meditation Deep brain stimulation This...

Ayana Jordan, MD, PhD , is the Barbara Wilson Associate Professor of Psychiatry at the NYU Grossman School of Medicine , an Associate Professor in the Department of Population Health , and the Pillar Lead for the Institute for Excellence in Health Equity . Topics covered: Lack of improvement in health equity nationwide Advice for clinicians on providing equitable care Structural competence vs. cul...

Lenard A. Adler, MD , is a Professor of Psychiatry and Child and Adolescent Psychiatry at the NYU Grossman School of Medicine and Director of the Adult ADHD Program at NYU Langone Health.  Topics covered: Symptomology (incl. sluggish cognitive tempo) Screening and diagnostic tools Pharmacological treatments (and recent developments) Cognitive behavioral therapy (CBT) Medication shortage Approaches...

Dan Iosifescu, MD , is an Associate Professor of Psychiatry at the NYU Grossman School of Medicine and director of clinical research at the Nathan Kline Institute for Psychiatric Research . His research has led to the validation of novel treatments for patients with severe mood and anxiety disorders, including pharmacological treatments such as ketamine and other glutamatergic drugs, and devices s...

Charles R. Marmar, MD , is the Peter H. Schub Professor of Psychiatry and Chair of the Department of Psychiatry at NYU Langone Health. He also serves as Director of the Center for Precision Medicine in Alcohol Use Disorders and Post-Traumatic Stress Disorder (PTSD) and as Executive Director of the Steven A. Cohen Military Family Center. Topics covered: The shortcomings of existing "gold-stand...